The Startup That Quietly Rewired European Healthcare
Before founding Docplanner, Mariusz GralewskiDealroom has a profile for this one. Try Dealroom → had already tasted success. In the mid-2000s, he built and sold GoldenLine , Poland’s answer to LinkedIn—a professional networking site that became a staple across Central Europe. After the sale, he turned to a more frustrating problem: booking a doctor.
In 2012, getting a medical appointment in Poland was like stepping into the past—paper forms, long hold times, no transparency. Gralewski’s insight was simple but powerful: patients want convenience and trust; doctors want filled calendars and fewer no-shows. That led to Docplanner, a platform to search, review, and book doctors online.
Early growth came fast, but scaling across borders was tricky. Healthcare is local. Naming, regulation, patient behavior—it all varies. So instead of imposing a single global brand, Docplanner localized aggressively. In Spain and Latin America, they merged with Doctoralia . In Italy, they launched MioDottore . In Turkey, they went in early and hard, becoming market leader.
But the turning point came when Docplanner realized the marketplace was only half the opportunity. Doctors needed tools. The team began building SaaS products: appointment scheduling, patient messaging, invoicing, digital records, and even reputation management. The result? Clinics didn’t just list on Docplanner—they ran on it. Churn dropped. Revenue diversified. And patients benefited from a smoother, more integrated experience.
By 2022, Docplanner had over 2,000 employees, and had raised more than $300M from firms like Point Nine, Target Global, and One Peak. That same year, they acquired Jameda , Germany’s top doctor review and booking platform, pushing further into Europe’s largest healthcare market.
The numbers speak volumes: 110 million annual bookings, 250,000+ healthcare providers, presence in 13 countries. Their flywheel runs on network effects and software lock-in—classic dual-sided platform strategy, but tailored to an archaic industry slow to digitize.
In 2023, Gralewski handed the CEO role to Diego Oliva, a former Facebook exec, signaling a new phase. Now Docplanner isn’t just about making doctor visits easier—it’s becoming the digital backbone of healthcare systems in fragmented markets worldwide.
While others chase AI hype cycles, Docplanner quietly built real infrastructure. Not glamorous, not loud—but deeply embedded. And that’s exactly what makes it such a durable, under-the-radar giant.
